Journal
TRENDS IN BIOTECHNOLOGY
Volume 41, Issue 12, Pages 1488-1500Publisher
CELL PRESS
DOI: 10.1016/j.tibtech.2023.07.003
Keywords
-
Categories
Ask authors/readers for more resources
The fields of tissue bioengineering, -omics, and spatial biology offer the opportunity for a paradigm shift in breast cancer research. However, collaboration between these fields has not reached its full potential. This review discusses the latest 3D breast cancer models, their biomaterials and technological platforms, as well as their biological evaluation, highlighting the potential for better microphysiological systems, improved drug development success rates, and personalized medicine approaches.
The fields of tissue bioengineering,-omics, and spatial biology are advancing rapidly, each offering the opportunity for a paradigm shift in breast cancer research. However, to date, collaboration between these fields has not reached its full potential. In this review, we describe the most recently generated 3D breast cancer models regarding the biomaterials and technological platforms employed. Additionally, their biological evaluation is reported, highlighting their advantages and limitations. Specifically, we focus on the most up-to-date-omics and spatial biology techniques, which can generate a deeper understanding of the biological relevance of bioengineered 3D breast cancer in vitro models, thus paving the way towards truly clinically relevant microphysiological systems, improved drug development success rates, and personalised medicine approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available